Drugs / TECHNETIUM (99MTC) ETARFOLATIDE
TECHNETIUM (99MTC) ETARFOLATIDE
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01686256 | Aug 2001 → Aug 2004 | endometrial cancer, ovarian cancer | Endocyte | Completed | No outcome recorded |
| Phase 1 | NCT01689636 | Aug 2000 → Jul 2002 | ovarian cancer | Endocyte | Completed | No outcome recorded |
| Phase 25 trials | ||||||
| Phase 2 | NCT01689766 | Nov 2003 → Nov 2007 | renal cell carcinoma | Endocyte | Completed | No outcome recorded |
| Phase 2 | NCT01689714 | Aug 2003 → Aug 2005 | endometrial carcinoma, ovarian carcinoma | Endocyte | Completed | No outcome recorded |
| Phase 2 | NCT01684098 | Aug 2003 → Aug 2005 | head and neck cancer, malignant pancreatic neoplasm, metastatic malignant neoplasm, testicular cancer +1 | Endocyte | Completed | No outcome recorded |
| Phase 2 | NCT01689727 | Sep 2002 → Sep 2004 | pituitary tumor | Endocyte | Completed | No outcome recorded |
| Phase 2 | NCT01689662 | Aug 2002 → Jul 2003 | renal cell carcinoma | Endocyte | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TECHNETIUM (99MTC) ETARFOLATIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707391 ↗ |
| Known as | 99mTc-EC20 | “Technetium Tc 99m EC20 (99mTc-EC20; FolateScan), a folate-targeted diagnostic radiopharmaceutical” NCT01689714 ↗ |
| Known as | FalateScan | “FalateScan (Technetium Tc 99m EC20)” NCT01684098 ↗ |
| Known as | FolateScan | “The investigational new drug (FolateScan or Technetium Tc 99m EC20) is a folate-targeted diagnostic radiopharmaceutical agent designed to bind to the folate receptor.” NCT01689766 ↗4“The investigational new drug (FolateScan or Technetium Tc 99m EC20) is a folate-targeted diagnostic radiopharmaceutical designed to bind to the folate receptor.” NCT01689662 ↗ “Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer” NCT01686256 ↗ “Technetium Tc 99m EC20 (99mTc-EC20; FolateScan), a folate-targeted diagnostic radiopharmaceutical” NCT01689714 ↗ “Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors” NCT01689727 ↗ |
| Known as | Tc 99m EC20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01689714 ↗ |
| Known as | Technetium Tc 99m EC20 | “The investigational new drug (FolateScan or Technetium Tc 99m EC20) is a folate-targeted diagnostic radiopharmaceutical designed to bind to the folate receptor.” NCT01689662 ↗3“Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer” NCT01686256 ↗ |
| Known as | Technetium tc 99m etarfolatide | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707391 ↗ |
| Known as | Technetium tc 99m pterotetramide | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707391 ↗ |
| Known as | Tecnecio (99mtc) etarfolatida | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707391 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic radiopharmaceutical designed to bind to the folate receptor” NCT01689662 ↗ |
| Route | Intravenous | “Subjects will receive two intravenous injections 1-3 minutes apart” NCT01689662 ↗ |